SHLP-2 peptide
SHLP-2 (Small Humanin-Like Peptide 2) is a naturally occurring peptide encoded by mitochondrial DNA and belongs to a group of signaling molecules known as mitochondria-derived peptides (MDPs). These peptides are involved in communication between mitochondria and the rest of the cell, helping regulate cellular metabolism and stress responses.
Small Humanin‑Like Peptide 2 was identified during research investigating small peptides encoded within the mitochondrial genome that may influence biological processes related to aging, metabolism, and cellular protection.
Because of its biological activity in experimental models, SHLP-2 has been studied in research related to mitochondrial function, metabolic regulation, and age-related cellular processes.
Although SHLP-2 peptide occurs naturally in the human body, synthetic versions used in research are considered experimental compounds and have not been approved as pharmaceutical medications.
How SHLP-2 peptide works
SHLP-2 has been studied for its potential role in regulating cellular metabolism and mitochondrial signaling. Experimental research suggests that the peptide may:
influence mitochondrial energy metabolism
modulate signaling pathways related to cell survival and stress resistance
affect biological mechanisms associated with insulin signaling and glucose metabolism
contribute to regulation of cellular responses to oxidative stress
Because mitochondria play a central role in energy production and metabolic regulation, mitochondria-derived peptides such as SHLP-2 are of interest in research focused on metabolic health and longevity biology.
However, the precise biological mechanisms of SHLP-2 in humans remain under investigation.
Clinical trials and evidence
Research involving SHLP-2 peptide has primarily been conducted in laboratory studies and animal models examining mitochondrial signaling and metabolic regulation. Experimental studies have explored:
the role of mitochondrial peptides in metabolic homeostasis
effects of SHLP-2 on insulin sensitivity and glucose metabolism in experimental systems
cellular pathways involved in mitochondrial stress responses
Some preclinical studies have suggested that SHLP-2 may influence metabolic signaling pathways and cellular protection mechanisms.
However, the peptide has not undergone extensive clinical trials in humans, and most available information comes from preclinical research rather than controlled clinical studies.
Possible side effects of SHLP-2:
Because SHLP-2 has primarily been studied in experimental settings, its complete safety profile in humans has not been fully established. Possible or theoretical side effects may include:
headache
fatigue
mild metabolic changes
injection site reactions
Further research is required to determine the long-term safety and potential risks associated with experimental applications of this peptide.